Refine
Year of publication
Document Type
- Article (16)
- Doctoral Thesis (1)
Has Fulltext
- yes (17) (remove)
Is part of the Bibliography
- no (17)
Keywords
- Cirrhosis (2)
- HBV (2)
- HIV (2)
- Hepatitis C virus (2)
- Protease inhibitor therapy (2)
- hepatitis C virus (2)
- APRI (1)
- Antiviral agents (1)
- Antiviral immune response (1)
- Antiviral therapy (1)
- Biomarkers (1)
- Chronic hepatitis (1)
- DAA (1)
- Extracellular matrix proteins (1)
- FIB-4 (1)
- HCV (1)
- Hepatitis C, Chronic (1)
- Hepatocellular carcinoma (1)
- Interferons (1)
- Liver cirrhosis (1)
- Liver transplantation (1)
- Medical education (1)
- NS5A (1)
- RAS (1)
- Specimen preparation and treatment (1)
- Viral load (1)
- acoustic radiation force impulse imaging (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- arachidonic acid (1)
- biomarker (1)
- co-infection (1)
- core expression (1)
- direct-acting antivirals (1)
- exosomes (1)
- fibrotest (1)
- genotype G (1)
- hepatic fibrosis (1)
- hepatitis C (1)
- immune escape (1)
- innate immunity (1)
- insulin resistance (1)
- interferon (1)
- non-invasive fibrosis assessment (1)
- omega-3 fatty acids (1)
- point shear wave elastography (1)
- prevalence (1)
- protein evolution (1)
- protein folding (1)
- resistance mutation (1)
- serine protease (NS3-4A) (1)
- sphingolipid (1)
- transient elastography (1)
- viral fitness (1)
- virologic failure (1)
Background: Accurate assessment of hepatic fibrosis in patients with chronic HBeAg-negative Hepatitis B is of crucial importance not only to predict the long-term clinical course, but also to evaluate antiviral therapy indication. The aim of this study was to prospectively assess the utility of point shear wave elastography (pSWE) for longitudinal non-invasive fibrosis assessment in a large cohort of untreated patients with chronic HBeAg-negative hepatitis B virus (HBV) infection.
Methods: 407 consecutive patients with HBeAg-negative HBV infection who underwent pSWE, transient elastography (TE) as well as laboratory fibrosis markers, including fibrosis index based on four factors (FIB-4), aspartate to platelet ratio index (APRI) and FibroTest, on the same day were prospectively followed up for six years. Patients were classified into one of the three groups: inactive carriers (IC; HBV-DNA <2000 IU/mL and ALT <40 U/L); grey zone group 1 (GZ-1; HBV DNA <2000 IU/mL and ALT >40 U/L); grey zone group 2 (GZ-2; HBV-DNA >2000 IU/mL and ALT <40 U/L).
Results: pSWE results were significantly correlated with TE (r = 0.29, p < 0.001) and APRI (r = 0.17; p = 0.005). Median pSWE values did not differ between IC, GZ-1 and GZ-2 patients (p = 0.82, p = 0.17, p = 0.34). During six years of follow-up, median pSWE and TE values did not differ significantly over time (TE: p = 0.27; pSWE: p = 0.05).
Conclusion: Our data indicate that pSWE could be useful for non-invasive fibrosis assessment and follow-up in patients with HBeAg-negative chronic HBV infection.